尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Siebert John M, 董事. Director active across 1 company, notably Supernus Pharmaceuticals, INC.. Cumulatively, 4 filings have been logged. Activity tracked since 11 August 2021. The latest transaction was disclosed on 23 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
John M. Siebert is a Director at Supernus Pharmaceuticals, Inc. He brings expertise in management and strategy, contributing to the governance of the company. His role is essential in guiding strategic decisions and ensuring compliance with regulations.